Back
Vertex Pharmaceuticals Stock Price Chart
Buy
72
VRTX
Vertex Pharmaceuticals
Last Price:
445.29
Seasonality Move:
7.52%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 425.94 | Buy |
20-day SMA: | 409.87 | Buy |
50-day SMA: | 408.97 | Buy |
200-day SMA: | 387.7 | Buy |
8-day EMA: | 426.84 | Buy |
20-day EMA: | 415.79 | Buy |
50-day EMA: | 411.37 | Buy |
200-day EMA: | 389.65 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.87 | Buy |
Relative Strength Index (14 RSI): | 77.11 | Buy |
Chaikin Money Flow: | 953136 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (392.44 - 421.32) | Buy |
Bollinger Bands (100): | (403.62 - 429.44) | Buy |
Vertex Pharmaceuticals Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 440.64 while VRTX 8-day simple moving average is 425.94, which is a Buy signal.
- The stock price of VRTX is 440.64 while Vertex Pharmaceuticals 20-day SMA is 409.87, which makes it a Buy.
- Vertex Pharmaceuticals 50-day simple moving average is 408.97 while VRTX share price is 440.64, making it a Buy technically.
- VRTX stock price is 440.64 and Vertex Pharmaceuticals 200-day simple moving average is 387.70, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
72
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $440.64. The Score for VRTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
113.71B
Price in USD:
440.64
Share Volume:
1.22M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
448.40
52-Week Low:
320.01
Buy
72
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 440.64 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 440.64 while VRTX 8-day exponential moving average is 426.84, which is a Buy signal.
- The stock price of VRTX is 440.64 while Vertex Pharmaceuticals 20-day EMA is 415.79, which makes it a Buy.
- Vertex Pharmaceuticals 50-day exponential moving average is 411.37 while VRTX share price is 440.64, making it a Buy technically.
- VRTX stock price is 440.64 and Vertex Pharmaceuticals 200-day simple moving average is 389.65, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is 7.87, suggesting Vertex Pharmaceuticals is a Buy
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 77.11, which suggest Vertex Pharmaceuticals is overbought
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (392.44 - 421.32), which suggest Vertex Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (403.62 - 429.44), which suggest Vertex Pharmaceuticals is a Buy
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.